Tyrosine Kinase

Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-   B1402 GZD824Target: Bcr-AblSummary: Bcr-Abl inhibitor,novel orally bioavailable B1402 GZD824Target: Bcr-AblSummary: Bcr-Abl inhibitor,novel orally bioavailable
-   B1526 Tandutinib (MLN518)Summary: FLT3 inhibitor,potent and selective B1526 Tandutinib (MLN518)Summary: FLT3 inhibitor,potent and selective
-   B4985 CH5183284 (Debio-1347)Summary: selective and orally available FGFR inhibitor B4985 CH5183284 (Debio-1347)Summary: selective and orally available FGFR inhibitor
-   B3686 DMH-1Target: BMP and Other Activin ReceptorsSummary: Selective BMP ALK2 receptor B3686 DMH-1Target: BMP and Other Activin ReceptorsSummary: Selective BMP ALK2 receptor
-   B4728 KX1-004Summary: Pp60c-src inhibitor B4728 KX1-004Summary: Pp60c-src inhibitor
-   A3433 Gefitinib hydrochlorideTarget: EGFRSummary: Potent EGFR inhibitor A3433 Gefitinib hydrochlorideTarget: EGFRSummary: Potent EGFR inhibitor
-   A3846 SU14813 maleateSummary: VEGFR/PDGFR/Kit/FLT-3 inhibitor A3846 SU14813 maleateSummary: VEGFR/PDGFR/Kit/FLT-3 inhibitor
-   A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met inhibitor,non-ATP-competitive A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met inhibitor,non-ATP-competitive
-   B2282 KX2-3911 CitationSummary: Src inhibitor,highly selective B2282 KX2-3911 CitationSummary: Src inhibitor,highly selective
-   B1011 Bafetinib (INNO-406)2 CitationSummary: Bcr-Abl/Lyn tyrosine kinase inhibitor B1011 Bafetinib (INNO-406)2 CitationSummary: Bcr-Abl/Lyn tyrosine kinase inhibitor
